In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer
KRAS-driven lung cancers represent an aggressive form of NSCLC. In this study the authors perform an in vivo functional screening and identify GATAD2B as a driver of tumor growth and metastasis in KRAS-driven lung cancer.
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d3a32362fb643e9a451c28f602e01e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7d3a32362fb643e9a451c28f602e01e5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7d3a32362fb643e9a451c28f602e01e52021-12-02T17:33:17ZIn vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer10.1038/s41467-018-04572-32041-1723https://doaj.org/article/7d3a32362fb643e9a451c28f602e01e52018-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-04572-3https://doaj.org/toc/2041-1723KRAS-driven lung cancers represent an aggressive form of NSCLC. In this study the authors perform an in vivo functional screening and identify GATAD2B as a driver of tumor growth and metastasis in KRAS-driven lung cancer.Caitlin L. GrzeskowiakSamrat T. KunduXiulei MoAndrei A. IvanovOksana ZagorodnaHengyu LuRichard H. ChappleYiu Huen TsangDaniela MorenoMaribel MosquedaKarina EterovicJared J. FradetteSumreen AhmadFengju ChenZechen ChongKen ChenChad J. CreightonHaian FuGordon B. MillsDon L. GibbonsKenneth L. ScottNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Caitlin L. Grzeskowiak Samrat T. Kundu Xiulei Mo Andrei A. Ivanov Oksana Zagorodna Hengyu Lu Richard H. Chapple Yiu Huen Tsang Daniela Moreno Maribel Mosqueda Karina Eterovic Jared J. Fradette Sumreen Ahmad Fengju Chen Zechen Chong Ken Chen Chad J. Creighton Haian Fu Gordon B. Mills Don L. Gibbons Kenneth L. Scott In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
description |
KRAS-driven lung cancers represent an aggressive form of NSCLC. In this study the authors perform an in vivo functional screening and identify GATAD2B as a driver of tumor growth and metastasis in KRAS-driven lung cancer. |
format |
article |
author |
Caitlin L. Grzeskowiak Samrat T. Kundu Xiulei Mo Andrei A. Ivanov Oksana Zagorodna Hengyu Lu Richard H. Chapple Yiu Huen Tsang Daniela Moreno Maribel Mosqueda Karina Eterovic Jared J. Fradette Sumreen Ahmad Fengju Chen Zechen Chong Ken Chen Chad J. Creighton Haian Fu Gordon B. Mills Don L. Gibbons Kenneth L. Scott |
author_facet |
Caitlin L. Grzeskowiak Samrat T. Kundu Xiulei Mo Andrei A. Ivanov Oksana Zagorodna Hengyu Lu Richard H. Chapple Yiu Huen Tsang Daniela Moreno Maribel Mosqueda Karina Eterovic Jared J. Fradette Sumreen Ahmad Fengju Chen Zechen Chong Ken Chen Chad J. Creighton Haian Fu Gordon B. Mills Don L. Gibbons Kenneth L. Scott |
author_sort |
Caitlin L. Grzeskowiak |
title |
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
title_short |
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
title_full |
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
title_fullStr |
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
title_full_unstemmed |
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer |
title_sort |
in vivo screening identifies gatad2b as a metastasis driver in kras-driven lung cancer |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/7d3a32362fb643e9a451c28f602e01e5 |
work_keys_str_mv |
AT caitlinlgrzeskowiak invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT samrattkundu invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT xiuleimo invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT andreiaivanov invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT oksanazagorodna invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT hengyulu invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT richardhchapple invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT yiuhuentsang invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT danielamoreno invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT maribelmosqueda invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT karinaeterovic invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT jaredjfradette invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT sumreenahmad invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT fengjuchen invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT zechenchong invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT kenchen invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT chadjcreighton invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT haianfu invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT gordonbmills invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT donlgibbons invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer AT kennethlscott invivoscreeningidentifiesgatad2basametastasisdriverinkrasdrivenlungcancer |
_version_ |
1718380009991700480 |